Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04466306 · ClinicalTrials.gov registry record

Pediatric Acute Kidney Injury in COVID-19

A clinical trial, sponsored by Children's Healthcare of Atlanta.

Completed
Registry status
400
Enrollment target

NCT04466306 is a clinical trial that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04466306 has completed, sponsored by Children's Healthcare of Atlanta.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

This study is an observational registry of children with or suspected to have SARS CoV2 (COVID-19) admitted to pediatric intensive care units (PICU). This registry will help describe the prevalence, rate and severity of acute kidney injury (AKI) in children with Severe Acute Respiratory Syndrome Coronavirus-2(SARS CoV2) across the world. The registry will be developed using a point prevalence methodology and then full retrospective review. Once a week, from April through June 2020, data collection will occur in "real-time" to estimate a weekly point prevalence of AKI and renal replacement therapy (RRT). The operational definition of "patients under investigation" (PUIs) will be used to identify the denominator of patients to be studied. The PUIs will be cohorted into SARS CoV2 test positive, test negative, test pending, or test unavailable. The primary aim of this study is to deliver a global, objective data driven analysis of the burden of AKI in virus positive patients or patients under investigation (PUI) who are admitted to the pediatric intensive care unit.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-04-15
Est. Completion 2021-07-01

Sponsor

Children's Healthcare of Atlanta

80 total trials

What the Registry Record Tells You About NCT04466306

The ClinicalTrials.gov registry entry for NCT04466306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04466306 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04466306 about?

NCT04466306 is a clinical study titled "Pediatric Acute Kidney Injury in COVID-19". This study is an observational registry of children with or suspected to have SARS CoV2 (COVID-19) admitted to pediatric intensive care units (PICU). This registry will help describe the prevalence, rate and severity of acute kidney injury (AKI) in children with Severe Acute Respiratory Syndrome Cor...

What is the current status of trial NCT04466306?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2020-04-15. Estimated completion is 2021-07-01.

Who is sponsoring clinical trial NCT04466306?

This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.